News

2021 Journal Mentions

March 15, 2022

During 2021, these head and neck cancer research reports noted Brandon’s Foundation as source of funding:

Newton HS, Chimote AA, Arnold MJ, Wise-Draper, TM & Conforti L (2021). Targeted knockdown of the adenosine A2A receptor by lipid NPs rescues the hemotaxis of head and neck cancer memory T cells. Mol Ther Methods Clin Dev; 21:133-143, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005736/.

 

Newton HS, Gawali VS, Chimote AA, Lehn MA, et al (2020). PD1 blockade enhances K+ channel activity, Ca2+ signaling, and migratory ability in cytotoxic T lymphocytes of patients with head and neck cancer. J Immunother Cancer; 8(2);1-16, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566435/. (A more user-friendly explanation of this research may be found via Channeling the Immune System – New findings uncover clues into why immunotherapy only works for some with head and neck cancer, https://www.uc.edu/news/articles/2020/11/uc-study-uncovers-clues-as-to-why-immunotherapy-for-cancer-works-for-some-and-not-others.html.)